Glenmark Pharma receives ANDA approval for Clobetasol Propionate Ointment

Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Clobetasol Propionate Ointment USP, 0.05 percent, the generic version of Temovate Ointment, 0.05 percent of Fougera Pharmaceuticals Inc.

March 21, 2017 / 09:32 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Sub:- Glenmark Pharmaceuticals receives ANDA approval for Clobetasol Propionate Ointment USP, 0.05% With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record.Source : BSE

Read all announcements in Glenmark

first published: Mar 21, 2017 09:32 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347